Triclabendazole

Kathryn Dzintars, PharmD, BCPS, Paul G. Auwaerter, M.D.

INDICATIONS

FDA

Triclabendazole was approved in 2019 for treating fasciola in individuals ≥ 6 years.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: December 11, 2022